In patients with CRP > 1 mg/L, responders (vs. current MDD, that is, unmedicated and non-responders) have consistent inhibition of pathways related to the interactions between immune cells and the immune receptors functioning (scavenger, Fc, and B cell receptors). This evidence concerns the gene CRP and major depressive disorder.